ROCKWELL MEDICAL, INC. Fair Value Adjustment of Warrants
ROCKWELL MEDICAL, INC. (RMTI) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-04-08
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for the quarter ending 2021-12-31 was $0.00.
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for the quarter ending 2021-09-30 was $0.00.
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for the quarter ending 2021-03-31 was $0.00.
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for fiscal 2020 was $837.00K.
- ROCKWELL MEDICAL, INC. fair value adjustment of warrants for fiscal 2019 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $0.00 derived: sum of 2 quarters · filed 2022-04-08 | $0.00 derived: sum of 3 quarters · filed 2022-04-08 | $0.00 10-K · filed 2022-04-08 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2022-04-08 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2022-04-08 | $0.00 derived: sum of 4 quarters · filed 2022-04-08 | ||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2022-04-08 | $0.00 derived: sum of 2 quarters · filed 2022-04-08 | $0.00 derived: sum of 3 quarters · filed 2022-04-08 | $837.00K derived: sum of 4 quarters · filed 2022-04-08 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $0.00 derived: sum of 2 quarters · filed 2022-04-08 | $837.00K derived: sum of 3 quarters · filed 2022-04-08 | $837.00K 10-K · filed 2022-04-08 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $837.00K derived: sum of 2 quarters · filed 2021-11-15 | $837.00K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $837.00K 10-Q · filed 2021-08-16 | $837.32K 10-Q · filed 2020-08-10 | $837.00K 10-Q · filed 2021-08-16 | $837.32K 10-Q · filed 2020-08-10 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |